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Abstract 
Magnetic resonance angiography (MRA) is a non-invasive technology that can be used for diagnosis and monitoring 
of cardiovascular disease; the number one cause of mortality worldwide.  
Hyperpolarized imaging agents provide signal enhancement of more than 10,000 times, which implies large 
reduction in acquisition time and improved spatial resolution. We review the role of hyperpolarized 
13
C agents for 
MR angiography and present the literature in the field. Furthermore, we present a study of the benefit of intra-
arterial injection over intravenous injection of hyperpolarized agent for cerebral angiography in the rat, and compare 
the performance of two standard angiographic pulse sequences, the gradient echo (GRE) sequence and the balanced 
steady-state free precession (bSSFP).  
2D coronal cerebral angiographies using intra-arterial injections were acquired with a GRE sequence with in-plane 
resolution of 0.27 mm and matrix size 256x128, and 2D coronal cerebral angiographies were acquired with a bSSFP 
sequence with in-plane resolution of 0.55 mm and matrix size 128x64.  
The bSSFP sequence provides higher SNR in phantoms than the GRE sequence. Similarly, intravenous injections 
are imaged with higher SNR with the bSSFP sequence, where the signal destruction of the GRE sequence is 
avoided. However, for intra-arterial injections, the bSSFP sequence results in strong artefacts, and the GRE 
sequence is preferred.  
Hyperpolarized MRA presents many challenges and cannot currently compete with conventional contrast enhanced 
MRA. Further research may change this since hyperpolarization is still an immature methodology. 
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Introduction 
Angiographic techniques are important in the diagnosis and treatment of medical conditions such as emboli, stenosis 
and intracranial aneurysms. The most frequently applied angiographic techniques are ultrasound imaging (US), 
computed tomography (CT), and nuclear medicine imaging such as PET [1]. US is non-invasive, but has its 
limitations in imaging of the cerebrovascular system, where cranium and tissue-bone interfaces cause attenuation 
and disturbance of the signal. CT provides high resolution images within short acquisition time, but the radiation 
exposure is a major limitation of repeated use. PET angiography can provide information about the functional 
metrics in the vascular system, however the low spatial resolution and the administration of radioactive contrast 
agent makes PET less preferable [2,3]. Magnetic resonance angiography (MRA) is generally used with a contrast 
agent based on e.g. gadolinium [4] that reduces the T1 of the blood, but flow-dependent techniques such as time-of-
flight (TOF) or phase contrast can also be employed without injections [5,6]. One class of MRA contrast agents 
includes blood pool agents such as Clariscan™; ultra-small super paramagnetic iron oxide particles that stay in 
circulation for hours [7]. Thus, the arterial vascular system alone can be imaged during the first pass of the contrast 
agent, whereas the entire vascular system can be acquired in a large time window allowing signal averaging for high 
resolution. Time-resolved fast imaging can be applied to capture the dynamics [8]. 
Hyperpolarized 
13
C MRA  
Conventional coronary proton MRA acquisition time depends on parameters such as matrix size and repetition time, 
and is typically acquired over several minutes [9]. Thus, respiratory and cardiac motion, as well as movements of the 
patient will affect the image quality. The need for faster image acquisition has catalyzed research in hyperpolarized 
(HP) MRI, where the signal can be enhanced by orders of magnitude compared to the thermal signal [10]. The 
polarization is obtained via dissolution Dynamic Nuclear Polarization (DNP): The sample is mixed with an Electron 
Paramagnetic Agent (EPA) and cooled to low temperature in a magnetic field, by which the unpaired electrons of 
the EPA reach a polarization of unity. The polarization of the electrons is transferred to the nuclear spins by 
irradiating with microwaves at the resonance frequency of the electrons. The high polarization of the nuclear spins 
are preserved to the liquid phase by rapidly dissolving in a dissolution medium, before the agent is injected. The 
polarization of the injected volume is more than 4 orders of magnitude larger than the thermal signal of
 13
C. 
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Therefore, the signal in a 
13
C image obtained after injection of a hyperpolarized substance is proportional to the 
concentration of the agent in question, and the image acts as a qualitative map of perfusion [11-14]. Likewise, the 
conversion of hyperpolarized 
13
C-labelled compounds such as pyruvate can be followed with Magnetic Resonance 
Spectroscopic Imaging (MRSI)[15-17], and the metabolic activity monitored [18]. 
Hyperpolarized MRA provides imaging of the injected substance in the vascular system, and thus provides a direct 
signal from the hyperpolarized spins in the blood. In addition, hyperpolarized MRA is not dependent on flow 
velocity as e.g. TOF-imaging, where flow close to the vessel walls appears with a low signal due to low flow 
velocity. In 2002 Golman et al. demonstrated that angiography in rats using hyperpolarized 
13
C is possible with bis-
1,1-(hydroxymethyl)-[1-
13
C]cyclopropane-D8 (HP001) as imaging agent and demonstrated that both ParaHydrogen-
Induced Polarization (PHIP)[19] and dissolution DNP [20] can be used for hyperpolarized 
13
C angiography with i.v. 
agent administration (Figure 1). Svensson et al. [21] studied 
13
C cerebral MRA in the rat and found that high SNR 
can be obtained in both the head and neck area (Figure 2) and in the thoracic/abdominal region using the balanced 
steady state free precision pulse sequence (bSSFP). Later, Olsson et al. [22] presented a study on hyperpolarized 
13
C 
coronary MRA in a pig model with i.a. injection. Recently, hyperpolarized H2O has been applied in angiography 
with the advantage of applicability on clinical scanners with 
1
H channels only, as well as higher achievable 
magnetization due to a larger magnetic moment [23]. 
For cerebral angiography in the rat, the hyperpolarized substance is typically injected using either intravenous (i.v.) 
injection through one of the tail veins, or intra-arterial (i.a.) injection where a catheter is operated into one of the 
carotid arteries. The injection method affect the system in various ways and e.g. movement of the catheter and the 
reaction of the vessels to increased pressure will result in difference in signal-to-noise ratio (SNR) and artefacts in 
the images. Thus, the MR sequence must be chosen and optimized in accordance with the injection method. 
Furthermore, the injection type will enhance specific characteristics of the arterial and venous network. An even 
distribution in the vasculature should be observed with an intravenous injection when the hyperpolarized substance 
is distributed through the heart of the animal. When the substance is injected in a carotid artery, only arteries 
branching from that specific carotid artery as well as the corresponding veins are highlighted. 
13
C agent and MRI considerations 
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The 
13
C-labelled agent HP001 is chosen for its long T1 (in vitro, 2.35 T: T1 ≈ 82 s, T2  ≈ 18 s; in vivo, 2.35 T: T1  ≈ 
38 s, T2  ≈ 1.3 s)[21]. This means that the signal decay should be caused mainly by dilution in the vasculature and 
extravasation of the agent to the surrounding tissue, and to a smaller extent by relaxation processes. 
The bSSFP imaging technique has been demonstrated to be a rapid, high-SNR technique for angiography and 
spectroscopic applications using hyperpolarized substances (Figure 2)[21,22,24,25]. The gradient echo (GRE) 
technique has been used extensively for single resonance HP lung imaging [26-28], but less for HP- angiography 
using 
13
C-labeled substances. A theoretical basis and in vitro measurement comparison between bSSFP and GRE for 
the HP angiography application was performed by Svensson et al. [21], but in vivo comparisons between the 
combinations of the two imaging techniques (bSSFP and GRE) and the two injection techniques (i.v. and i.a.) is to 
our knowledge not performed. 
In this review we demonstrate the current possibilities of a hyperpolarized 
13
C-labelled agent for MRA and 
investigate the difference between intravenous and intra-arterial injection with the GRE and bSSFP imaging 
sequences. 
Methods 
Polarization 
Bis-1,1-(hydroxymethyl)-[1-
13
C]cyclopropane-D8 (HP001) was used as the imaging agent to obtain long relaxation 
times of the 
13
C nuclei. Trityl OX063 (Oxford Instruments, Abingdon UK) was used as paramagnetic agent. A batch 
consisting of 18.0 mg OX063, 500 mg HP001, 180 mg water and 15 µL Dotarem (1:10 dilution, Guerbet, Paris, 
France) was prepared. 100 µL sample was polarized using an Oxford Instruments Hypersense, 3.35 T, 1.4 K, by 
irradiation with microwaves at 94.112 GHz for one hour. The polarization time constant was 1800 s. The sample 
was dissolved in 1 mL PBS buffer with 0.01 g/L EDTA diluted in 3 mL NaCl (9 g/L). The 
13
C concentration in the 
final solution was 100 mmol/L. The solution temperature was approximately 37 °C and the pH 7.5-8. The time from 
dissolution to injection start was 14-18 s and the polarization was 20-25% at time of injection. 
Animal Preparation 
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All animal experiments were carried out in compliance with the guidelines for use and care of laboratory animals 
and were approved by the Danish Inspectorate of Animal Experiments, approval 2012-15-2934-00244. 
Male Sprague Dawley rats weighing 240-320 g were anaesthetized with 1.8% isoflurane in air mixed with 5 % 
oxygen adjusted to a respiration rate of 75±10 min
-1
 and mounted in an animal holder. The body temperature was 
kept at 38±1 °C with hot air flow. 
Tail vein catherization: A catheter was inserted in a tail vein for i.v. contrast agent administration. A volume of 1.5 
mL was injected over 6-9 s. 
Carotid artery catherization: Carotid artery injections were prepared by incision in the ventral neck of the rat and 
isolation of the right carotid artery, before inserting and securing the catheter in the artery. The catheter was fixed to 
the skin with tape. A volume of 1.0 mL was injected over 6-9 s. 
MR scanner system and pulse sequences: 
Data was acquired on a 4.7 T imaging system (Agilent, Direct Drive, VnmrJ 4.0) using a 
13
C/
1
H RF volume coil 
combined with a 
13
C 4-channel surface array coil (receive-only, 50 mm inner diameter, RAPID Biomedical GmbH, 
Germany). The receive coil was placed dorsal with the animal supine. Figure 3 shows the profile of the coil 
sensitivity measured as the sum-of-squares image of a CSI acquisition of a spherical bicarbonate phantom. The 
position of the GRE slab is indicated as the shaded area. The bSSFP slab is overlapping, but extends 10 mm in the 
anterior direction. The sensitivity is highest in the region closest to the coil elements, thus the sensitivity of the 
vessels in this region is more than twice the sensitivity in the outer region of the slab. The system was shimmed to a 
proton line width of less than 110 Hz over the field-of-view (FOV). The image reconstruction applied the sum-of-
squares algorithm where the signal in each pixel is the square root of the sum of the squares of the signal from each 
individual array coil element. The background noise is measured in a ROI of 20x20 pixels in an area away from the 
hyperpolarized signal. 
Coil Sensitivity measurements:  The coil sensitivity is assessed with a CSI pulse sequence with FOV 80x80 mm
2
, 
matrix size 16x16, α = 10°, TR = 75 ms on a spherical phantom of 1.0 M bicarbonate (38 mm diameter). 
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HP-
13
C-MRA - bSSFP: The hyperpolarized signals were acquired using a single-shot bSSFP sequence with 110° flip 
angle (α). An α/2-pulse preparation pulse was implemented at time TR/2 before the first excitation pulse to approach 
a steady state like situation faster and a corresponding flip-back pulse was implemented at the end of each image 
acquisition to restore the longitudinal magnetization for the following time frame. The angiographic images had a 
Field-Of-View (FOV) of 70x35 mm
2
 and a slab thickness of 30 mm placed coronal in the head and neck region. The 
matrix size was 128x64. The repetition time and echo time were set to minimum, TR/TE = 6.95/3.48 ms. A 
bandwidth of 50 kHz yielded a total image acquisition of 450 ms for each image. The sequence was started when the 
solution had been fully injected to capture the maximum possible signal. 
HP-
13
C-MRA, GRE: The GRE sequence was applied with an FOV of 70x35 mm
2
, a slab thickness of 20 mm and 
with matrix size 256x128. The pulse length was 2 ms and the repetition and echo times were TR/TE = 10.16/5.10 
ms. The total acquisition time for an image was 1300 ms with α = 5° and imaging was repeated over 30 time frames. 
Acquisition was started when injection was initiated to capture the maximum signal strength. 
1
H MRA: Proton angiographic images were acquired with a 1H quadrature coil (M2M imaging corporation, 
Cleveland, Ohio, USA) with inner diameter of 35 mm. A 3D GRE sequence with TR/TE = 90/2.47 ms, α = 40°, 
FOV of 30x35x20 mm
3
, matrix size 256x256x64 was used after an intravenous injection of 50 µL Clariscan™ 
(NC100150, NYCOMED IMAGING AS, Oslo, Norway). The total acquisition time was 25 minutes. 
Results  
1
H MRA: Figure 4 shows a contrast enhanced 
1
H 3D GRE image of the cerebral vascular system. The large arrow 
indicates the superior sagittal sinus (SSS), the small arrows indicate the transverse sinuses (TRS) and the dotted 
arrows indicate the superficial temporal vein (STEMV), posterior facial. 
HP-
13
C-MRA, GRE: An excitation pulse flip angle of 5° was found the optimal compromise between signal strength 
and conversion of magnetization during the time series in a separate study (data not shown). A time series of 8 
frames during intra-arterial injection is shown in Figure 5. The best image is the 4
th
 time frame. The rat brain was 
centered in the FOV, and arteries and veins of the right side of the head appear with the largest denseness around the 
brain and towards the nose region. Only a few veins appear in the left half of the image, and only minor signal 
contribution is visible in the eye region of the right side. Figure 6 shows the 4
th
 frame as overlay on the proton 
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image. Though the two angiographies are obtained on different animals and positioning, the images are in agreement 
and major venal structures (SSS, TRS, STEMV) of the right side are identified. 
A series of 3 consecutive intra-arterial injections of hyperpolarized HP001 in an animal with intervals of 
approximately one hour gave SNR 26, 19 and 20, as measured as the ratio between the largest signal observed and 
the background noise, and demonstrates reproducibility of the result. 
18 injections in 10 animals yielded SNR of 17.6±4.5 (Mean±SD). 
The corresponding GRE acquisition after an intravenous injection yielded signal from the larger veins but with SNR 
lower than 10 (acquired in 3 animals, image not shown). 
HP-
13
C-MRA, bSSFP: The signal acquisition bandwidth was studied in the range of 20-100 kHz, and we found 50 
kHz to be the optimal balance between high signal and minimal flow artefacts. The sequence was started when the 
solution had been fully injected to capture the maximum possible signal. In separate experiments (data not shown), 
the flip angle for the bSSFP- sequence was optimized on thermal phantom experiments where a flip angle of 110° 
yielded a 22% higher SNR than the corresponding experiment with 60° flip angle and where flip angles higher than 
110° did  experiments on HP in vivo experiments with the bSSFP (data not shown). A time series of bSSFP acquired 
images with one second intervals is shown in Figure 7. SNR of 36 is observed in the first frame and the signal 
decays rapidly in the following frames. The larger veins (SSS, TRS, STEMV) identified from the overlay appear 
distinctly in a symmetrical shape, and smaller venal structure appears towards the nose region. 
5 injections in 4 different animals yielded SNR of 31.3±20.0 (Mean±SD). 
Discussion 
In this study we injected a dose close to the anticipated clinical dose of ca. 0.4 mmol/kg, which is only 25-50% of 
the dose used in previous studies with a similar polarization. We obtained results similar to Golman et al., where an 
SNR of 34 was demonstrated in a 128x128 matrix (70x70 mm
2
) in the rat heart with an injection of 2-3 mL of 200 
mM (ca. 1.5 mmol/kg) solution with polarization of ca. 15% [19]. Svensson et al. obtained SNR of 74-76 in a lower 
resolution of a 64x64 matrix (70x70 mm
2
) placed in the rat head and neck region with injection of 3-3.5 mL of 200 
mM solution with a polarization of ca. 15% [21].  
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The bSSFP sequence proved best for injections through the tail vein where the physiological and physical reactions 
of the animal are negligible, in contrary to injections through a carotid artery, which caused minor mechanical 
movements of the neck and head region where the catheter is inserted, as well as possible physiological reactions in 
the imaged region due to the injected bolus’ impact on the vessels due to pressure, pH, temperature and tonicity. 
These movements caused motion artefacts in the bSSFP acquisition, whereas a GRE sequence was more robust to 
displacements and hence better suitable. Images of carotid artery injection acquired with bSSFP (Figure 8) showed a 
very high SNR of 137. Even though this large signal from the high agent concentration in the arteries was observed, 
the details of the vascular system were indistinguishable. The sequence was applied with TR/TE = 6.95/3.48 ms, α = 
60° in a 128x128 matrix with FOV 60x60 mm
2
 in a 30 mm slab. The strong artefacts may be caused by motion due 
to the injection as well as B0-field disturbances caused by the large difference in oxygenated blood and the water 
introduced with the injection [29]. 
The contrast agent is further diluted for tail vein injections. The combination of small flip angle GRE acquisition and 
large dilution in the vascular system resulted in SNR below 10. Therefore, a bSSFP sequence with high flip angle is 
preferred.  
The bSSFP-sequence had a slab thickness of 30 mm. In some experiments, the transverse sinuses align orthogonally 
to the slice and thus contribute with a large signal in the projection (arrow in Figure 7). These outliers cause the 
large variance where single pixels have yielded signal strength much larger than the rest of the vasculature.  
Large parts of the image characteristics in Figure 5 are observed throughout the series, while some features are 
vanishing in the later time steps. The fact that the operated carotid has been sealed off beneath the catheter explains 
that some of the branches have closed off during several hours of occlusion in the scanner. The image series and the 
consistency in the SNR indicate that polarization, injection and data acquisition is reproducible.  
When the bSSFP sequence was applied following an intra-arterial injection we observe motion artefacts in the phase 
encoding direction as shown in Figure 8.  
Polarizers for DNP have now been installed in several clinics around the world, and studies of HP 
13
C in humans 
initiated [30]. As this equipment is being implemented, the application of hyperpolarized agents for angiography in 
will be further studied, and a potential translation towards application in clinical practice explored.  
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In conclusion, intravenous and intra-arterial injection techniques were used in combinations with optimized GRE- 
and bSSFP-imaging, respectively, for rat cerebral MRA with a hyperpolarized 
13
C-labelled agent, and resulted in 
bSSFP-imaging being preferable for intravenous injections, and GRE-imaging being preferable for the intra-arterial 
injection technique. 
Hyperpolarized 
13
C MRA is currently unable to compete with contrast enhanced MRA. Considering the complexity 
of the method (primarily the need for polarizer hardware and the short life time of the signal) it is unlikely that it 
will become an attractive method. However, hyperpolarization is still an immature methodology, and there are areas 
where current MRA falls short. With further research into hyperpolarization to increase the available signal, and 
possibly increase the life time, there are opportunities for significant improvement. 
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Figure legends 
Figure 1: Angiographic image of the rat heart region after i.v. injection in the tail vein. Acquired with a gradient 
spoiled, gradient echo sequence (TE/TR = 4 ms/9.5 ms, FA = 10°, FOV = 70x70 mm
2
, matrix = 128x128, slice = 30 
mm, scan time = 2 s). With permission from [19] and Elsevier. 
Figure 2: First image in a series of angiograms covering the head and neck region. The image has been acquired on a 
2.35 T animal MRI system with a trueFISP sequence (TE/TR = 1.8 ms/3.6 ms, FOV = 70x70 mm
2
, and matrix = 
64x64, with read oversampling). Major vessels appear with SNR of 74-76, but some enhancement of other tissue is 
observed as well. With permission from [21] and John Wiley and Sons. 
Figure 3: The vertical sensitivity profile of the coil from a sum of squares CSI image of a spherical bicarbonate 
phantom (small insert). The FOV and slab position of the i.v. (bSSFP) acquisitions and the thinner slab of the i.a. 
(GRE) acquisitions are indicated. 
Figure 4: Coronal image of cerebral vessel structure acquired with a 3D gradient echo sequence after injection of 
NC100150. The large arrow indicates the superior sagittal sinus, the small arrows indicate the transverse sinuses, 
and the dotted arrows indicate the superficial temporal vein. 
Figure 5: Time series of GRE images initiated after injection of hyperpolarized HP001 through the right carotid 
artery. 1.3 s between each frame. 
Figure 6: Image of GRE sequence (4
th
 frame) initiated after injection of hyperpolarized HP001 through the right 
carotid artery as overlay on the proton image of Figure 4. The veins SSS, TRS (right) and STEMV (right) coincide 
and the structure of finer vessels appear in the overlay. 
Figure 7: bSSFP time series after finished injection of hyperpolarized HP001 though the tail vein, 1 s between 
frames. Right image shows the first image as overlay on the proton image of Figure 4. The veins SSS, TRS and 
STEMV coincide while smaller vessels are not distinguishable.  
Figure 8: bSSFP acquired image after intra-arterial injection demonstrates high SNR of 137 and artefacts due to 
motion and susceptibility change. 
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